[Prognostic value of hormonal and immunological indices in the combined treatment of esophageal cancer].
A combination therapy consisting of two endolymphic infusions of BCG vaccine and methotrexate followed by remote gamma therapy 10 days after the second infusion was given to 96 patients with stage III esophageal tumors. Complete response was observed in 64.4 and partial--in 33.3% of cases. An evaluation of response carried out on the basis of 40 hormonal and immunological indices showed that immunological factors make the major contribution to antitumor resistance. The report contains a table of parameters which provide information indispensable for the prognosis of treatment depending on the response of internal environment to endolymphic infusion.
D000328:Adult; D000368:Aged; D001500:BCG Vaccine / Q000008:administration & dosage; D004938:Esophageal Neoplasms / Q000175:diagnosis* / Q000276:immunology / Q000628:therapy; D005260:Female; D005500:Follow-Up Studies; D005720:Gamma Rays / Q000627:therapeutic use; D006728:Hormones / Q000378:metabolism; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D011379:Prognosis; D012044:Regression Analysis
D001500:BCG Vaccine; D006728:Hormones; D008727:Methotrexate
Prognosticheskaia tsennost' gormonal'nykh i immunologicheskikh pokazateleĭ pri kompleksnom lechenii raka pishchevoda.